GlassScriptPhysician profile
Khaled Imad Khalaf
NPI 1710237250
$185,059.98
in general payments reported to CMS, 2019-2025
73 companies · $45K in 2025
The $45K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $11K · 2021: $14K · 2022: $27K · 2023: $31K · 2024: $45K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Food and Beverage: $24K · Travel and Lodging: $14K · Long Term Medical Supply Or Device Loan: $13K · Entertainment: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,250.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,055.00 |
| Food and Beverage | $24,356.04 |
| Travel and Lodging | $13,934.94 |
| Long Term Medical Supply Or Device Loan | $13,486.11 |
| Entertainment | $134.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $38,979.36 | 2021-2025 | Venaseal, Corevalve Evolut R, Endurant Iis |
| Cvrx, INC. | $37,369.50 | 2020-2025 | Barostim Neo System |
| Cardiva Medical, INC. | $16,458.08 | 2019-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f, Other |
| Angiodynamics, INC. | $14,955.75 | 2020-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13,576.54 | 2019-2025 | Lifevest |
| Abbott Laboratories | $10,904.26 | 2019-2025 | Xience Xpedition, Cardiomems, Perclose Prostyle |
| Atricure, INC. | $9,040.02 | 2021-2023 | |
| Inari Medical, INC. | $7,423.66 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $6,403.13 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $5,955.06 | 2019-2020 | |
| Veryan Medical Incorporated | $3,760.51 | 2021-2025 | Biomimics 3d Vascular Stent System |
| Novartis Pharmaceuticals Corporation | $2,310.44 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $1,943.47 | 2021-2024 | Optimizer, Optimizer |
| Boston Scientific Corporation | $1,633.81 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Varithena Administration Pack |
| Bard Peripheral Vascular, INC. | $1,476.26 | 2019-2025 | Rotarexs 6 F X 135 Cm, Lifestream, Venovo |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $961.96 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $767.17 | 2021-2025 | Torus Stent Graft System, Endocross Device |
| Cardiovascular Systems INC. | $750.42 | 2019-2023 | |
| Abiomed | $700.46 | 2019-2024 | Impella |
| Merck Sharp & Dohme LLC | $645.04 | 2021-2025 | Verquvo, Steglujan, Steglatro |
| Asahi Intecc USA, INC. | $598.18 | 2023-2025 | Asahi Ptca Guide Wire, Asahi Peripheral Vascular Wires, Peripheral Vascular |
| Astrazeneca Pharmaceuticals LP | $556.93 | 2019-2023 | Farxiga |
| Amgen INC. | $540.37 | 2019-2025 | Repatha |
| Pfizer INC. | $529.91 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $520.44 | 2019-2025 | Camzyos, Eliquis |
| Tactile Systems Technology INC | $519.93 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Heartflow, INC. | $472.40 | 2019-2025 | |
| Esperion Therapeutics, INC. | $385.35 | 2020-2024 | Nexletol |
| Kestra Medical Technology Services, INC. | $375.97 | 2025 | Assure Wcd |
| Novo Nordisk INC | $313.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Philips North America LLC | $281.86 | 2019-2023 | |
| Teleflex LLC | $269.11 | 2019-2025 | Guideliner |
| Amarin Pharma, INC. | $243.74 | 2019-2022 | |
| Penumbra, INC. | $234.55 | 2019 | |
| Biotronik INC. | $227.64 | 2019-2022 | |
| Silk Road Medical, INC. | $209.34 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.99 | 2019-2025 | Jardiance |
| W. L. Gore & Associates, INC. | $199.20 | 2025 | Gore Cardioform Septal Occluder |
| Chiesi USA, INC. | $195.58 | 2019-2025 | Kengreal |
| Recor Medical INC | $188.38 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Endotronix, INC. | $146.57 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Edwards Lifesciences Corporation | $139.43 | 2020-2025 | Sapien 3 Ultra Resilia |
| Opsens INC. | $134.66 | 2023 | Optowire |
| Resmed Corp | $131.18 | 2022-2023 | |
| Astellas Pharma US INC | $126.58 | 2019-2021 | |
| Microtransponder, INC. | $125.28 | 2023 | |
| Itamar Medical INC | $101.26 | 2022 | |
| Canon Medical Systems USA, INC. | $98.83 | 2023 | Pet-Ct Scanner |
| Cordis US Corp. | $98.80 | 2023 | Radial 360, Mynx Control |
| Cardiofocus, INC. | $97.89 | 2020 | |
| Zoll Circulation INC | $86.51 | 2020-2022 | |
| Bolton Medical INC | $65.63 | 2020 | |
| Regeneron Pharmaceuticals, INC. | $64.92 | 2019-2025 | Evkeeza |
| Biocompatibles, INC. | $62.75 | 2019 | |
| Argon Medical Devices, INC. | $60.05 | 2025 | Clot Management |
| Sanofi-Aventis U.S. LLC | $59.23 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $49.55 | 2023-2025 | Uptravi, Opsumit |
| Inspire Medical Systems, INC. | $44.40 | 2024 | Inspire |
| Surmodics, INC. | $41.45 | 2024 | Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Cashflow Solutions, LLC | $30.97 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Lexicon Pharmaceuticals, INC. | $28.67 | 2023 | Inpefa |
| Biohaven Pharmaceutical Holding Company LTD. | $26.92 | 2022 | |
| Medicure Pharma INC. | $21.14 | 2022 | |
| Avinger INC. | $20.86 | 2021 | |
| Tandem Diabetes Care, INC. | $17.19 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $15.86 | 2025 | |
| Siemens Medical Solutions USA, INC. | $15.05 | 2021 | |
| Lemaitre Vascular, INC. | $13.96 | 2019 | |
| Becton, Dickinson and Company | $13.39 | 2024 | Rotarexs 6 F X 135 Cm |
| Ekos Corporation | $12.09 | 2019 | |
| Cook Medical LLC | $11.20 | 2020 | |
| Irhythm Technologies, INC. | $10.99 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaled Khalaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.